MOSCOW (Reuters) – Russia’s third vaccine against COVID-19, CoviVac, is more than 80% effective according to preliminary data, the Interfax news agency cited the vaccine’s developer as saying on Wednesday.
The Chumakov Centre could produce six times more than the previously planned 10 million doses of the vaccine a year, Interfax added.
(Reporting by Maria Kiselyova; Writing by Alexander Marrow; Editing by David Goodman)
Jalen Brunson returns from foot injury, sparks Knicks past Pacers for 2-0 lead in East semifinals
Aleksander Barkov scores twice, Panthers rout Bruins 6-1 in Game 2 to tie series
Canucks overcome 3-goal deficit to stun Oilers 5-4 in Game 1
Jalen Brunson returns for NY in 2nd half of Game 2 vs. Pacers, then Anunoby exits with injury
Jokic wins NBA’s MVP award, his 3rd in 4 seasons. Gilgeous-Alexander and Doncic round out top 3
Europe Day marks 1 month till EU elections. Rise of hard right, wilting of Green Deal are possible
China criticizes US for ship’s passage through Taiwan Strait, weeks before new leader takes office
Transitional council in Haiti embraces new changes following turmoil as gang violence grips country
Tornadoes tear through southeastern US as storms leave 3 dead
Torchbearers in Marseille kick off the Olympic flame’s journey across the country
Kenya’s public hospital doctors sign agreement to end national strike after almost 2 months
How a Texas man is testing out-of-state abortions by asking a court to subpoena his ex-partner
Underpaid and overworked. Colleges, universities having trouble hiring, retaining athletic trainers
Steward Health Care says it is selling the 30+ hospitals it operates nationwide
